期刊文献+

影响枯草芽孢杆菌fmbR菌株抗菌物质提取的主要因子 被引量:20

The main factors affecting the extraction of the antimicrobial substance from Bacillus subtilis fmbR strain using Plackett-Burman Design
下载PDF
导出
摘要 应用P lackett-Burm an Design对枯草芽孢杆菌fmbR菌株抗菌物质提取的主要影响因子(甲醇、乙醇、丙醇、正丁醇、pH值和时间)进行了研究。JMP软件分析结果表明:影响抗菌物质提取的关键因素为乙醇(P<0.000 1)、正丁醇(P<0.000 1)、pH值(P=0.002 5)和时间(P=0.008 3)。在实验范围内,乙醇、正丁醇和时间对抗菌物质提取总量有显著正效应,pH值与抗菌物质提取总量呈显著负相关。抗菌物质提取总量最高预测值可达21.82 mg.100 mL-1,其概率为99.79%。 In order to evaluate the importance of the selected six factors, including methanol, ethanol, propanol, butanol, pH and time, on the extraction of the antimicrobial substance produced by Bacillus subtilis fmbR strain, the Plackett-Burman Design method was applied. The main factors that affect the extraction of the antimicrobial substance were determined as ethanol (P 〈0. 000 1 ), butanol ( P 〈0. 000 1 ), pH ( P =0. 002 5 ), time ( P =0. 008 3 ) by using JMP software. Within the tested ranges, ethanol, butanol and time showed the significant positive relativity to the total extracted amounts; while pH had a significant negative effect. The maximum prediction profile indicated that the total extracted amounts for the antimicrobial substance would reach 21.82 mg·100 mL^-1 with 99.79% probability.
出处 《南京农业大学学报》 CAS CSCD 北大核心 2005年第4期126-129,共4页 Journal of Nanjing Agricultural University
基金 江苏省高新技术项目(BG2003311)
关键词 枯草芽孢杆菌 抗菌物质 提取 JMP软件 主要因子 Bacillus subtilis antimicrobial substance extraction JMP software main factors
  • 相关文献

参考文献10

  • 1Nakayma S, Takahashi M, Hirai M, et al. Isolation of new variants of surfactin by a recombinant Bacillus subtilis [J]. Applied Microbiol Biotechnol, 1997, 48:80 ~82.
  • 2Gluliano B, Andres H, Luigi C. Isolation and partial purification of a metabolite from a mutant strain of Bacillus sp. with antibiotic activity against plant pathogenic agents [J]. Journal of Biotechnology, 2002, 5: 1 ~8.
  • 3Kenji T, Takahashi A, Makoto S. Isolation of a gene essential for biosynthesis of the lipopeptide antibiotics plipastatin B1 and surfactin in Bacillus subtilis YB8 [J]. Archive Microbiology, 1996, 165:243 ~251.
  • 4Palk S H, Chakicheria A, Hansen J N. Identification and characterization of the structural and transporter genes for the chemical and biological properties of sublancin 168, a novel lantibiotic produced by Bacillus subtilis 168 [J]. J Biol Chem, 1998, 273:23134 ~23142.
  • 5Hansen J N. Antibiotics synthesized by post translational modification [J]. Annu Rev Microbiol, 1993, 47:535 ~564.
  • 6Bie Xiaomei, Lu Zhaoxin, Lu Fengxia, et al. Screening the main factors affecting extraction of the antimicrobial substance from Bacillus sp.fmb J using the Plackett-Burman method [J]. World Journal of Microbiology and Biotechnology, 2005, 21: 925 ~928.
  • 7Plackett R L, Burman J P. The design of optimum multifactorial experiments [ J]. Biometrika, 1946, 33:305 ~ 325.
  • 8LandyM, Warren GH, RosenmanS, etal. An antibiotic from Bacillus subtilis active against pathogenic fungi [J]. Proceedings of the Society for Experimental Biology and Medicine, 1948, 67:539 ~ 541.
  • 9Cho S J, Lee S K, Cha B J, et al. Detection and characterization of the Gloeosporium gloesporioides growth inhibitory compound iturin A from Bacillus subtilis strain KS03 [J]. Fermentation Microbiology Letters, 2003, 223:47 ~51.
  • 10Weng C C, Barrie W B, Mark L L, et al. Sequence-specific resonance assignment and conformational analysis of subtilin by 2D NMR [J].European Biochemical Societies, 1992, 300: 56 ~ 62.

同被引文献229

引证文献20

二级引证文献217

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部